Chad Messer
Stock Analyst at Lake Street
(0.55)
# 3,787
Out of 4,829 analysts
23
Total ratings
34.78%
Success rate
-26.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LTRN Lantern Pharma | Initiates: Buy | $25 | $4.11 | +508.27% | 1 | Apr 2, 2025 | |
| IMNM Immunome | Initiates: Buy | $23 | $7.94 | +189.67% | 1 | Apr 2, 2025 | |
| OSTX OS Therapies | Initiates: Buy | $19 | $1.70 | +1,017.65% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $0.80 | +14,169.62% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $10.68 | +368.38% | 1 | Jul 27, 2021 | |
| CYTK Cytokinetics | Maintains: Buy | $33 → $48 | $32.13 | +49.39% | 2 | Jul 19, 2021 | |
| EXEL Exelixis | Maintains: Buy | $33 → $30 | $36.98 | -18.88% | 3 | Jun 28, 2021 | |
| RNA Avidity Biosciences | Initiates: Buy | $50 | $29.33 | +70.47% | 1 | Jun 17, 2021 | |
| CRMD CorMedix | Maintains: Buy | $31 → $29 | $11.86 | +144.52% | 2 | May 14, 2021 | |
| MREO Mereo BioPharma Group | Initiates: Buy | $10 | $2.50 | +300.00% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $33.53 | +156.49% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $0.95 | +7,836.51% | 1 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $10.18 | +332.22% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $36.37 | +356.42% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $2.43 | +640.74% | 1 | May 5, 2020 |
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $4.11
Upside: +508.27%
Immunome
Apr 2, 2025
Initiates: Buy
Price Target: $23
Current: $7.94
Upside: +189.67%
OS Therapies
Apr 2, 2025
Initiates: Buy
Price Target: $19
Current: $1.70
Upside: +1,017.65%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $0.80
Upside: +14,169.62%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $10.68
Upside: +368.38%
Cytokinetics
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $32.13
Upside: +49.39%
Exelixis
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $36.98
Upside: -18.88%
Avidity Biosciences
Jun 17, 2021
Initiates: Buy
Price Target: $50
Current: $29.33
Upside: +70.47%
CorMedix
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $11.86
Upside: +144.52%
Mereo BioPharma Group
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $2.50
Upside: +300.00%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $33.53
Upside: +156.49%
Mar 15, 2021
Initiates: Buy
Price Target: $75
Current: $0.95
Upside: +7,836.51%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $10.18
Upside: +332.22%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $36.37
Upside: +356.42%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $2.43
Upside: +640.74%